Looking for new takeover targets
The Evonik business is currently benefiting by the extremely low interest rates. The chemical giant is continuing lookout for potential acquisition objects. On sales of Bayer however one was not interested.
When asked whether Evonik'm interested in investments, the Dow and
Dupont have to sell in the course of their merger on antitrust grounds perhaps, Angel said, "Now that certainly all take a close look." Interest in possible sales of
Bayer / Monsanto contrast does not exist. The agricultural chemicals business play almost no role in the company.
Dusseldorf chemicals group Evonik looks around for takeover objects. He keep getting analyzes in which consultants made proposals, said Evonik CEO Klaus Engel of appearing in Dusseldorf "Rheinische Post" (Saturday edition). The competition to take, China and other countries were catching up. In addition, the business with acquisitions by the extremely low interest rates will be heated. Size alone is not a goal.